je.st
news
Biocodex USA Acquires Totect, Antidote For Unintended Tissue Damage From Chemotherapy
2013-04-02 09:00:00| drugdiscoveryonline News Articles
Biocodex USA announced recently its acquisition of the oncology supportive care product, Totect from Apricus Biosciences
Tags: usa
damage
tissue
chemotherapy
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||